SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 213 filers reported holding SAGE THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.62 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $161 | -56.2% | 7,834 | 0.0% | 0.00% | -66.7% |
| Q2 2023 | $368 | +60.7% | 7,834 | +43.6% | 0.00% | +50.0% |
| Q1 2023 | $229 | -13.9% | 5,457 | -21.6% | 0.00% | 0.0% |
| Q4 2022 | $266 | -99.9% | 6,964 | +3.5% | 0.00% | -33.3% |
| Q3 2022 | $264,000 | +24.5% | 6,729 | +2.4% | 0.00% | +50.0% |
| Q2 2022 | $212,000 | -28.6% | 6,574 | -26.8% | 0.00% | 0.0% |
| Q1 2022 | $297,000 | -62.4% | 8,978 | -51.7% | 0.00% | -33.3% |
| Q4 2021 | $790,000 | +4.5% | 18,578 | +8.9% | 0.00% | -50.0% |
| Q3 2021 | $756,000 | -24.2% | 17,054 | -2.8% | 0.01% | -25.0% |
| Q2 2021 | $997,000 | +113.9% | 17,543 | +182.0% | 0.01% | -52.9% |
| Q1 2021 | $466,000 | -19.1% | 6,220 | -6.6% | 0.02% | -22.7% |
| Q4 2020 | $576,000 | +41.2% | 6,659 | -0.3% | 0.02% | +22.2% |
| Q3 2020 | $408,000 | +46.8% | 6,676 | -0.0% | 0.02% | +38.5% |
| Q2 2020 | $278,000 | -27.4% | 6,678 | -49.9% | 0.01% | +44.4% |
| Q1 2020 | $383,000 | -60.8% | 13,323 | -1.7% | 0.01% | -50.0% |
| Q4 2019 | $978,000 | -44.8% | 13,551 | +7.3% | 0.02% | -51.4% |
| Q3 2019 | $1,772,000 | -13.1% | 12,630 | +13.3% | 0.04% | -22.9% |
| Q2 2019 | $2,040,000 | +16.1% | 11,143 | +0.9% | 0.05% | +11.6% |
| Q1 2019 | $1,757,000 | +80.4% | 11,044 | +8.6% | 0.04% | +53.6% |
| Q4 2018 | $974,000 | +10.6% | 10,168 | +63.0% | 0.03% | +27.3% |
| Q3 2018 | $881,000 | -47.0% | 6,238 | -41.3% | 0.02% | -46.3% |
| Q2 2018 | $1,663,000 | +83.6% | 10,621 | +88.9% | 0.04% | +70.8% |
| Q1 2018 | $906,000 | +6.8% | 5,623 | +9.2% | 0.02% | +4.3% |
| Q4 2017 | $848,000 | +209.5% | 5,147 | +16.9% | 0.02% | +155.6% |
| Q3 2017 | $274,000 | -21.5% | 4,403 | +0.6% | 0.01% | -18.2% |
| Q2 2017 | $349,000 | +33.2% | 4,378 | +18.6% | 0.01% | -15.4% |
| Q1 2017 | $262,000 | – | 3,692 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,966,688 | $120,204,000 | 10.81% |
| Integral Health Asset Management, LLC | 230,000 | $14,058,000 | 4.30% |
| Asymmetry Capital Management, L.P. | 102,462 | $6,262,000 | 4.02% |
| ACUTA CAPITAL PARTNERS, LLC | 225,000 | $13,752,000 | 3.74% |
| DAFNA Capital Management LLC | 158,306 | $9,676,000 | 3.14% |
| Bain Capital Life Sciences Investors, LLC | 499,100 | $30,505,000 | 2.84% |
| Boxer Capital, LLC | 1,094,000 | $66,865,000 | 2.31% |
| Palo Alto Investors LP | 590,200 | $36,073,000 | 1.98% |
| Logos Global Management LP | 250,000 | $15,280,000 | 1.96% |
| Bellevue Group AG | 1,579,504 | $96,539,000 | 1.33% |